These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1494306)

  • 21. The pharmacokinetics of eflornithine (alpha-difluoromethylornithine) in patients with late-stage T.b. gambiense sleeping sickness.
    Na-Bangchang K; Doua F; Konsil J; Hanpitakpong W; Kamanikom B; Kuzoe F
    Eur J Clin Pharmacol; 2004 Jun; 60(4):269-78. PubMed ID: 15141331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nifurtimox-eflornithine combination therapy for second-stage gambiense human African trypanosomiasis: Médecins Sans Frontières experience in the Democratic Republic of the Congo.
    Alirol E; Schrumpf D; Amici Heradi J; Riedel A; de Patoul C; Quere M; Chappuis F
    Clin Infect Dis; 2013 Jan; 56(2):195-203. PubMed ID: 23074318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of polyamine biosynthesis by alpha-difluoromethylornithine in African trypanosomes and Pneumocystis carinii as a basis of chemotherapy: biochemical and clinical aspects.
    McCann PP; Bacchi CJ; Clarkson AB; Bey P; Sjoerdsma A; Schecter PJ; Walzer PD; Barlow JL
    Am J Trop Med Hyg; 1986 Nov; 35(6):1153-6. PubMed ID: 3098121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-dose nifurtimox for arseno-resistant Trypanosoma brucei gambiense sleeping sickness: an open trial in central Zaire.
    Pépin J; Milord F; Meurice F; Ethier L; Loko L; Mpia B
    Trans R Soc Trop Med Hyg; 1992; 86(3):254-6. PubMed ID: 1412646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial.
    Mesu VKBK; Kalonji WM; Bardonneau C; Mordt OV; Blesson S; Simon F; Delhomme S; Bernhard S; Kuziena W; Lubaki JF; Vuvu SL; Ngima PN; Mbembo HM; Ilunga M; Bonama AK; Heradi JA; Solomo JLL; Mandula G; Badibabi LK; Dama FR; Lukula PK; Tete DN; Lumbala C; Scherrer B; Strub-Wourgaft N; Tarral A
    Lancet; 2018 Jan; 391(10116):144-154. PubMed ID: 29113731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of trypanosomes in suspected sleeping sickness patients in Uganda using the polymerase chain reaction.
    Kyambadde JW; Enyaru JC; Matovu E; Odiit M; Carasco JF
    Bull World Health Organ; 2000; 78(1):119-24. PubMed ID: 10686746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Innate lack of susceptibility of Ugandan Trypanosoma brucei rhodesiense to DL-alpha-difluoromethylornithine (DFMO).
    Iten M; Matovu E; Brun R; Kaminsky R
    Trop Med Parasitol; 1995 Sep; 46(3):190-4. PubMed ID: 8533023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. African sleeping sickness in the United States. Successful treatment with eflornithine.
    Petru AM; Azimi PH; Cummins SK; Sjoerdsma A
    Am J Dis Child; 1988 Feb; 142(2):224-8. PubMed ID: 3124603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Arsenical resistance and difluoromethylornithine in the treatment of human African trypanosomiasis].
    Kazyumba GL; Ruppol JF; Tshefu AK; Nkanga N
    Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):591-4. PubMed ID: 3143492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Susceptibility of Grammomys surdaster thicket rats to Trypanosoma brucei gambiense infection.
    Büscher P; Bin Shamamba SK; Ngoyi DM; Pyana P; Baelmans R; Magnus E; Van Overmeir C
    Trop Med Int Health; 2005 Sep; 10(9):850-5. PubMed ID: 16135191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human African trypanosomiasis in Angola: clinical observations, treatment, and use of PCR for stage determination of early stage of the disease.
    Truc P; Lando A; Penchenier L; Vatunga G; Josenando T
    Trans R Soc Trop Med Hyg; 2012 Jan; 106(1):10-4. PubMed ID: 22093811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eflornithine. A new drug in the treatment of sleeping sickness.
    Van Bogaert I; Haemers A
    Pharm Weekbl Sci; 1989 Jun; 11(3):69-75. PubMed ID: 2505225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DL-alpha-difluoromethylornithine (DFMO)-Berenil combination: therapeutic and prophylactic activity against Trypanosoma brucei brucei infection in mice.
    Onyeyili PA; Egwu GO; Zaria LT; Orjiude BA
    Rev Elev Med Vet Pays Trop; 1991; 44(4):443-5. PubMed ID: 1843826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Uveo-meningitis revealing a West African trypanosomiasis in a 12-year-old girl].
    Buissonnière RF; De Boissieu D; Tell G; Bursztyn J; Belliot P; Ponsot G
    Arch Fr Pediatr; 1989; 46(7):517-9. PubMed ID: 2512891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting the polyamine biosynthetic enzymes: a promising approach to therapy of African sleeping sickness, Chagas' disease, and leishmaniasis.
    Heby O; Persson L; Rentala M
    Amino Acids; 2007 Aug; 33(2):359-66. PubMed ID: 17610127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Equivalence trial of melarsoprol and nifurtimox monotherapy and combination therapy for the treatment of second-stage Trypanosoma brucei gambiense sleeping sickness.
    Bisser S; N'Siesi FX; Lejon V; Preux PM; Van Nieuwenhove S; Miaka Mia Bilenge C; Būscher P
    J Infect Dis; 2007 Feb; 195(3):322-9. PubMed ID: 17205469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo evaluation of sixteen plant extracts on mice inoculated with Trypanosoma brucei gambiense.
    Youan BB; Coulibaly S; Miezan TB; Doua F; Bamba M
    Bull World Health Organ; 1997; 75(4):343-8. PubMed ID: 9342893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination chemotherapy of drug-resistant Trypanosoma brucei rhodesiense infections in mice using DL-alpha-difluoromethylornithine and standard trypanocides.
    Bacchi CJ; Nathan HC; Yarlett N; Goldberg B; McCann PP; Sjoerdsma A; Saric M; Clarkson AB
    Antimicrob Agents Chemother; 1994 Mar; 38(3):563-9. PubMed ID: 8203855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The potentiation of arsenicals with difluoromethylornithine (DFMO): experimental studies in murine trypanosomiasis.
    Jennings FW
    Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):595-607. PubMed ID: 2848638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of drug resistance in Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense. Treatment of human African trypanosomiasis with natural products (Review).
    Gehrig S; Efferth T
    Int J Mol Med; 2008 Oct; 22(4):411-9. PubMed ID: 18813846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.